Harvard Bioscience, Inc.

Harvard Bioscience, Inc.

Harvard Bioscience, Inc.

Overview
Date Founded

2000

Headquarters

84 OCTOBER HILL ROAD, SUITE 10, HOLLISTON, MA, 017461371

Type of Company

Public

Employees (Worldwide)

505

Industries

Industrial Machinery & Manufacturing
Biotechnology

Company Description

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Contact Data
Trying to get in touch with decision makers at Harvard Bioscience, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman, President & Chief Executive Officer

Chief Financial Officer & Principal Accounting Officer

Chief Marketing Officer

Vice President EMEA, General Manager, Cellular & Molecular Technologies Sales

Vice President & General Manager, Electrophysiology

Vice President North America & APAC Sales, Cellular & Molecular Technologies

Vice President of Sales-Denville Scientific

Vice President Global Sales, Preclinical Systems

Chief Operating Officer

Vice President & General Manager-DSI

Board of Directors

Chairman, President & Chief Executive Officer at Harvard Bioscience, Inc.

Chief Executive Officer at Cambrex Corp.

President & Chief Executive Officer at Entegris, Inc.

Executive Vice President & Chief Financial Officer at OSI Systems, Inc.

Chief Executive Officer & Director at JMJ Associates LLP

Former Chief Financial Officer, Treasurer & Senior Vice President at RSA Security LLC

General Counsel at Checkmate Pharmaceuticals, Inc.

Former Chairman, President & Chief Executive Officer at Biostage, Inc.

Paths to Harvard Bioscience, Inc.
Potential Connections via
Relationship Science
You
Harvard Bioscience, Inc.
Owners & Shareholders
Details Hidden

Potomac Capital Management focuses in long/short investments in small/micro-cap stocks with a growth bias. The firm employs fundamental, bottom-up research to select their investments. Potomac Capital Management is an activist firm and is included in the SharkWatch50 as one the 50 most prominent activist investors.

Details Hidden

Punch & Associates incorporates a risk-averse investment philosophy centered on preserving and growing their clients’ assets. The firm is a multi-cap manager with the following core strategies: Income, Large-Cap Equity, and Small-Cap Equity, Micro-Cap and Nano-Cap Equity, and Strategic Total Return. Punch & Associates utilizes a bottom-up security selection process and applies a combination of qualitative and quantitative analysis to identify under-researched opportunities which generate current income and have the potential for long-term capital appreciation. Maintaining a focus on value, the firm selects securities that have sustainable and durable income streams. Importantly, they take an opportunistic and active management approach that seeks to take advantage of extreme investor behavior and exaggerated price movements.

Details Hidden

ACM’s investment objective is to seek to achieve risk-adjusted returns by investing in a long/short portfolio consisting primarily of small- and mid-capitalization securities while adhering to a focused risk management discipline. Current income is not an objective. The firm’s basic philosophy is to identify a core portfolio of small- to mid-capitalization companies traded in the US and foreign equity markets that it believes are undervalued compared to their historical relative valuations and growth potential and which possess catalysts that will accelerate sales and/or earnings growth. They use a disciplined, fundamental research, bottom-up investment approach to identify long and short investment opportunities. The investment style is oriented towards GARP with value, which implies the use of disciplined relative guidelines in both purchase and sale of securities. The decision to focus on small- and mid-capitalization stocks are based on what ACM believes is an area of the market that provides a high number of attractive investment opportunities on a valuation basis. ACM follows a disciplined investment process that it believes will allow it to identify potential investment opportunities in any market cycle.

Recent Transactions
Details Hidden

Harvard Bioscience, Inc. purchases Data Sciences International, Inc. from Canaan Management, Inc., Polaris Partners, Cross Creek Advisors LLC

Details Hidden

Thomas Scientific LLC purchases Denville Scientific, Inc. from Harvard Bioscience, Inc.

Details Hidden

Harvard Bioscience, Inc. purchases HEKA Elektronik Dr. Schulze GmbH

Transaction Advisors
Auditor

Advised onHarvard Bioscience, Inc. issued USD Common Stock

Legal Advisor

Advised onHarvard Bioscience, Inc. purchases Data Sciences International, Inc. from Canaan Management, Inc., Polaris Partners, Cross Creek Advisors LLC

Legal Advisor

Advised onHarvard Bioscience, Inc. purchases Genomic Solutions, Inc.

Legal Advisor

Advised onHarvard Bioscience, Inc. purchases Data Sciences International, Inc. from Canaan Management, Inc., Polaris Partners, Cross Creek Advisors LLC

Co-Chair, Venture Capital & Private Equity Practice

Advised onHarvard Bioscience, Inc. purchases Data Sciences International, Inc. from Canaan Management, Inc., Polaris Partners, Cross Creek Advisors LLC

Investor Relations Officer

Advised onHarvard Bioscience, Inc. purchases HEKA Elektronik Dr. Schulze GmbH

Clients

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Key Stats and Financials As of 2019
Market Capitalization
$164M
Total Enterprise Value
$171M
Earnings Per Share
$-0.12
Revenue
$116M
Total Equity
$81.7M
Net Profit
$-4.69M
EBITDA
$9.57M
EBITDAMargin
8.24%
Total Debt
$64.5M
Enterprise Value / Sales
1.48x
Enterprise Value EBITDAOperating
16.8x
TEVNet Income
-36.58x
Debt TEV
0.38x
Three Year Compounded Annual Growth Rate Of Revenue
3.59%
Five Year Compounded Annual Growth Rate Of Revenue
1.35%
Non-Profit Donations & Grants
$2,000 - $4,999
2009
Investors
Details Hidden

Founder at Harvard Bioscience, Inc.

Details Hidden

NEP focuses on investing in companies in the technology, healthcare, and consumer product industries. Within the technology sector, they concentrate on investing in companies in the Internet, software, hardware and communications industries. In healthcare, they target biopharmaceutical, biotechnology, medical device and e-health companies. In consumer products, they seek companies that can offer distinctive products in a mass-market retail channel setting.The firm seeks early and later stage companies that are beyond the concept stage, have demonstrable technology and evidence of product or service acceptance. For companies with greater financial needs, NEP has a history of syndicating with other reputable venture capital or strategic investors. They participate in all stages of a company's equity financing needs, from a first institutional round of equity to a mezzanine round before an IPO.NEP concentrates on investing in companies that target potentially large markets. In addition, they work closely with portfolio companies in setting goals and financial objectives to maximize the overall financial return of the company and its investors.They seek to invest in companies that offer the potential for a relatively early initial public offering or sale to a strategic buyer. They also assist their portfolio companies in achieving liquidity by way of a sale to a financial investor or through a recapitalization.

Details Hidden

Ascent Venture Management Inc. invest in early stage companies based in east coast US, cross Atlantic, Europe and Israel. It invests in Enterprise technology.

Suppliers
DKSH Holdings Malaysia Bhd. Wholesale: Raw Materials | Petaling Jaya, Malaysia

DKSH Holdings (Malaysia) Bhd. is an investment company, which engages in the provision of market expansion services such as marketing; sales force; distribution and logistics; invoicing and credit control; handling of inventory and returned goods; and other value added services. It operates through the following segments: Marketing and Distribution, Logistics, and Others. The Marketing and Distribution segment comprises the fast moving consumer goods and performance materials business. The Logistics segment provides warehousing and distribution, order processing, and sales collections for the healthcare business and parts of consumer goods business such as sales of telephone cards. The Others segment focuses on the Famous Amos chocolate chip cookie and central overheads businesses including property. The company was founded on December 24, 1991 and is headquartered in Petaling Jaya, Malaysia.

Competitors
Danaher Corporation Industrial Machinery & Manufacturing - Washington, DC

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

Thermo Fisher Scientific, Inc. Industrial Machinery & Manufacturing - Waltham, Massachusetts

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Becton, Dickinson & Co. Medical Products & Equipment - Franklin Lakes, New Jersey

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. BD is headquartered in the United States and has offices in more than 50 countries worldwide.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Harvard Bioscience, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Harvard Bioscience, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Harvard Bioscience, Inc..